-
Antiviral API
- Arenavirus
- Cytomegalovirus (CMV)
- Dengue virus
- Endogenous Metabolite
- Enterovirus (EV)
- Epstein-Barr virus (EBV)
- Filovirus
- Flavivirus
- HCV Protease
- Hepatitis B Virus (HBV)
- Hepatitis C Virus (HCV)
- Herpes simplex Virus (HSV)
- HIF/HIF Prolyl-Hydroxylase
- HIV Integrase
- HIV Protease
- Human immunodeficiency Virus (HIV)
- Human papillomavirus (HPV)
- Influenza Virus
- Nipah virus
- Orthopoxvirus
- Others
- Rabies virus (RABV)
- Respiratory syncytial Virus (RSV)
- Reverse Transcriptases (RTs)
- SARS-CoV
- Tobacco mosaic virus (TMV)
- Vesicular stomatitis virus (VSV)
- Virus Protease
- West Nile virus
- Antiviral intermediates
Elsulfavirine
![{PARAM:[Name]}()](https://resource.bocsci.com/structure/868046-19-9.gif)
| Category | Human immunodeficiency Virus (HIV) |
| CAS | 868046-19-9 |
| Description | Elsulfavirine is a non-nucleoside reverse transcriptase inhibitor (NNRTI) used for the treatment and prevention of human immunodeficiency virus (HIV) infection. |
Product Information
| Synonyms | Elpida; Benzeneacetamide, 4-bromo-3-(3-chloro-5-cyanophenoxy)-N-[2-chloro-4-[[(1-oxopropyl)amino]sulfonyl]phenyl]-2-fluoro-; 4-Bromo-3-(3-chloro-5-cyanophenoxy)-N-[2-chloro-4-[[(1-oxopropyl)amino]sulfonyl]phenyl]-2-fluorobenzeneacetamide |
| IUPAC Name | N-[4-[[2-[4-bromo-3-(3-chloro-5-cyanophenoxy)-2-fluorophenyl]acetyl]amino]-3-chlorophenyl]sulfonylpropanamide |
| Molecular Weight | 629.28 |
| Molecular Formula | C24H17BrCl2FN3O5S |
| Canonical SMILES | CCC(=O)NS(=O)(=O)C1=CC(=C(C=C1)NC(=O)CC2=C(C(=C(C=C2)Br)OC3=CC(=CC(=C3)C#N)Cl)F)Cl |
| InChI | InChI=1S/C24H17BrCl2FN3O5S/c1-2-21(32)31-37(34,35)17-4-6-20(19(27)11-17)30-22(33)9-14-3-5-18(25)24(23(14)28)36-16-8-13(12-29)7-15(26)10-16/h3-8,10-11H,2,9H2,1H3,(H,30,33)(H,31,32) |
| InChIKey | ULTDEARCBRNRGR-UHFFFAOYSA-N |
| Purity | ≥95% |
| Density | 1.68±0.1 g/cm3 (Predicted) |
| Solubility | Soluble in DMSO |
| Appearance | Solid Powder |
| Application | Anti-HIV Agents |
| Storage | Store at -20°C |
| Complexity | 977 |
| Exact Mass | 626.94334 |
| Target | HIV |
| XLogP3-AA | 5.2 |
